Public Health

For older patients, Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief --two new studies

New findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to a reduction in COVID-19 hospitalizations and death, as well as to faster resolution of symptoms and less use of healthcare resources.

Benefit seen only in older patients

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

H5N1 bird flu might be more prevalent among humans than public health data shows

As H5N1 bird flu continues to spread around the US, health officials recently found that 7 percent of dairy workers tested on farms in two states had evidence of recent infection — and some had signs of infection even when they didn’t feel sick.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Bird flu: first case reported in Canada

A teenager in British Columbia has become the first person in Canada to test positive for bird flu, authorities said Saturday. ...

Officials said the infection probably came from a bird or animal.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Analysis: Can one die from long COVID? The answer is not so simple

...

While long COVID is not usually immediately or directly life-threatening, it’s possible it could exacerbate existing conditions, and play a role in a person’s death in this way.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Public Health
howdy folks
Page loaded in 9.058 seconds.